100s of titles, one news app for just $10 a month.
Latest Business news:
FAA clears air taxi company to fly rich passengers above us plebs
Despite operating at a $62 million loss last quarter, Joby is that much closer to its 2024 takeoff date.
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
‘Highly implausible’ that new Galilee Basin coalmines would be profitable, study finds
Report says Adani’s Carmichael mine in central Queensland seems ‘rather a political decision, not an economically driven one’
Battered Appen mulls $1.2b takeover offer
A Sydney tech company whose shares are 85 per cent off its 2020 highs has received a takeover offer from…
Google Hit With Fresh UK Investigation Over Ad Tech Dominance
The UK’s antitrust watchdog started a new investigation of Alphabet Inc.’s Google, over suspicions it may have abused its dominant…
Russia prepares to seize western firms looking to leave
Russia is advancing a new law allowing it to take control of the local businesses of western companies that decide…
From analysis to good news, read the world’s best news in one place
Asian markets mostly down as Li remarks overshadow Fed minutes
Hong Kong (AFP) - Asian markets mostly fell Thursday as Chinese Premier Li Keqiang warned the world's number two economy…
Travel patterns have changed for good. Transport systems should, too
Enough with all the radii

12 Health Care Stocks Moving In Friday's After-Market Session

By Benzinga Insights

Gainers

  • Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their outstanding shares is at $38.0 million. As per the news, the Q1 earnings report came out 2 days ago.
  • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 12.96% to $1.48. The company's market cap stands at $27.5 million.
  • NantHealth (NASDAQ:NH) shares rose 9.53% to $0.65. The company's market cap stands at $75.1 million.
  • BioSig Technologies (NASDAQ:BSGM) stock moved upwards by 9.01% to $1.33. The market value of their outstanding shares is at $52.6 million.
  • Baudax Bio (NASDAQ:BXRX) stock moved upwards by 6.42% to $1.16. The company's market cap stands at $7.4 million.
  • Neoleukin Therapeutics (NASDAQ:NLTX) stock increased by 6.11% to $1.04. The market value of their outstanding shares is at $44.2 million. As per the press release, Q1 earnings came out 4 days ago.

Losers

  • Acutus Medical (NASDAQ:AFIB) shares decreased by 12.1% to $0.78 during Friday's after-market session. The company's market cap stands at $22.1 million. As per the press release, Q1 earnings came out yesterday.
  • Zosano Pharma (NASDAQ:ZSAN) shares declined by 11.58% to $1.68. The company's market cap stands at $8.2 million. The company's, Q1 earnings came out today.
  • PolarityTE (NASDAQ:PTE) shares fell 9.31% to $0.19. PolarityTE's trading volume hit 18.5 million shares by close, accounting for 292.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $17.1 million.
  • Venus Concept (NASDAQ:VERO) stock declined by 8.74% to $0.78. The company's market cap stands at $50.0 million. As per the press release, Q1 earnings came out yesterday.
  • Evoke Pharma (NASDAQ:EVOK) shares fell 8.29% to $0.25. The company's market cap stands at $8.2 million. As per the press release, Q1 earnings came out 3 days ago.
  • Akanda (NASDAQ:AKAN) shares fell 5.56% to $1.19. Trading volume for this security closed at 90.4K, accounting for 10.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.